With the approval, FDA granted SpringWorks a rare pediatric disease priority review voucher.
Industry Outlook 2025: Experts Weigh in on the Most Impactful Trends for Industry ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback